Barclays Issues Pessimistic Forecast for Omnicom Group (NYSE:OMC) Stock Price

Omnicom Group (NYSE:OMC) had its target price reduced by equities researchers at Barclays from $110.00 to $105.00 in a note issued to investors on Thursday,Benzinga reports. The firm currently has an “overweight” rating on the business services provider’s stock. Barclays‘s price objective suggests a potential upside of 43.52% from the company’s current price.

OMC has been the topic of a number of other research reports. Citigroup restated a “buy” rating and set a $103.00 price target on shares of Omnicom Group in a report on Tuesday. UBS Group decreased their target price on Omnicom Group from $117.00 to $104.00 and set a “buy” rating for the company in a report on Thursday, March 20th. Wells Fargo & Company dropped their price target on Omnicom Group from $99.00 to $84.00 and set an “equal weight” rating for the company in a research note on Wednesday. JPMorgan Chase & Co. decreased their price objective on shares of Omnicom Group from $116.00 to $104.00 and set an “overweight” rating for the company in a report on Wednesday. Finally, Argus lowered shares of Omnicom Group from a “buy” rating to a “hold” rating in a research note on Friday, February 14th. One analyst has rated the stock with a sell rating, two have given a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $101.29.

Omnicom Group Trading Up 2.7 %

Shares of OMC stock opened at $73.16 on Thursday. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.00 and a quick ratio of 0.90. Omnicom Group has a 1-year low of $69.13 and a 1-year high of $107.00. The business has a 50-day moving average of $79.57 and a 200 day moving average of $89.47. The stock has a market capitalization of $14.38 billion, a PE ratio of 9.82, a P/E/G ratio of 1.94 and a beta of 0.87.

Omnicom Group (NYSE:OMC) last announced its quarterly earnings results on Tuesday, April 15th. The business services provider reported $1.70 earnings per share for the quarter, beating the consensus estimate of $1.63 by $0.07. The business had revenue of $3.69 billion during the quarter, compared to analysts’ expectations of $3.73 billion. Omnicom Group had a net margin of 9.44% and a return on equity of 36.39%. As a group, sell-side analysts anticipate that Omnicom Group will post 8.25 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the business. Massachusetts Financial Services Co. MA increased its stake in shares of Omnicom Group by 50.1% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 5,973,061 shares of the business services provider’s stock valued at $513,922,000 after purchasing an additional 1,992,695 shares in the last quarter. Castlekeep Investment Advisors LLC bought a new position in Omnicom Group during the 4th quarter valued at approximately $150,819,000. FMR LLC raised its stake in Omnicom Group by 250.1% during the fourth quarter. FMR LLC now owns 2,010,547 shares of the business services provider’s stock valued at $172,987,000 after buying an additional 1,436,231 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in Omnicom Group by 91.8% in the fourth quarter. JPMorgan Chase & Co. now owns 2,147,019 shares of the business services provider’s stock worth $184,730,000 after acquiring an additional 1,027,567 shares in the last quarter. Finally, Raymond James Financial Inc. purchased a new stake in shares of Omnicom Group in the fourth quarter worth $79,321,000. 91.97% of the stock is currently owned by institutional investors.

About Omnicom Group

Omnicom Group Inc, together with its subsidiaries, offers advertising, marketing, and corporate communications services. It provides a range of services in the areas of advertising and media, precision marketing, commerce and branding, experiential, execution and support, public relations, and healthcare.